Amgen
Fortune 1000 1980 #129 by revenue · AMGN United States Healthcare Pharmaceuticals amgen.com
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics.
Fortune 1000's description, shown to identify the company. We rate the name, not the business.
- Evocativity EVOC : yellow
- Gen faintly hints at genetics
- Brevity BREV : green
- 5 letters, 2 syllables. Up to seven letters is green, eight at two syllables too; up to ten yellow, eleven or more red.
- Greppability GREP : green
- Found inside 0 other dictionary words.
- Googlability GOOG : green
- Distinctive coined whole
- Pronounceability PRON : yellow
- Gen may be pronounced jen or gen
- Spellability SPEL : yellow
- Amgen versus Amjen is uncertain by ear
- Verbability VERB : red
- No natural medicine action sense
- Nominology
- 73
- All seven dimensions and .com ownership, weighted as set out on Methodology.
- Fluency
- 70
- Brevity and pronounceability only: the subset with published outcome evidence behind it.
- PG grade
- 3 / 4
- Graham's own four-step ladder.
- Exact .com
- Owned
- Shape
- invented
- Length
- 5 chars, 2 syllables
- Distinctiveness
- suggestive
Watkins SCRATCH flags
- Curse-of-knowledge
This row is stitched from more than one source. Fortune 1000 supplied the company; forbes2000 filled year, country, and one_liner and S&P 500 / GICS filled subindustry.
Rubric version 2026.10.20-1, judged by gpt-6.1-sol (agent).
This scores the name only. See Methodology.
These judged dimensions came from an AI agent working through the judging queue in a chat, on the same rubric the scoring pipeline sends. The agent passed the calibration exam before its work was accepted, and each batch it judged hid two names with known answers as a check. The model is named as the agent reported it.